Antihyperglycaemic and antidyslipidemic activities in ethyl acetate fraction of fruits of marine mangrove Xylocarpus Moluccensis

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 1, 2014, Pages 809-826

  Srivastava, Arvind Kumar ^a   Tiwari, Priti ^a   Srivastava, Swayam Prakash ^a   Srivastava, Rohit ^a   Mishra, Akansha ^a   Rahuja, Neha ^a   Pandeti, Sukanya ^a   Tamrakar, Akhilesh Kumar ^a   Narender, Tadigoppula ^a   Srivastava, Mahendra Nath ^a   Lakshmi, Vijai ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Db db mice; Ethyl acetate fraction; Glucose uptake; Regulatory enzymes of Carbohydrate metabolism; Streptozotocin induced diabetic rats; Xylocarpus moluccensis

Indexed keywords

ALPHA GLUCOSIDASE; ENZYME; FENOFIBRATE; FRUCTOSE BIS PHOSPHATASE; GLUCOKINASE; GLYCOGEN PHOSPHORYLASE; GUM ARABIC; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLANT EXTRACT; PYRUVATE KINASE; UNCLASSIFIED DRUG; XYLOCARPUS MOLUCCENSIS FRUIT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIDYSLIPIDEMIC ACTIVITY; ARTICLE; BODY WEIGHT; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DYSLIPIDEMIA; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; IC 50; INSULIN BLOOD LEVEL; KIDNEY FUNCTION TEST; MALE; MELIACEAE; NONHUMAN; RAT; SINGLE DRUG DOSE; SYRIAN HAMSTER; TRIACYLGLYCEROL BLOOD LEVEL; XYLOCARPUS MOLUCCENSIS;

EID: 84891925232     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Horton ES, Can Newer Therapies Delay the Progression of Type 2 Diabetes Mellitus? Endocr. Pract. 2008; 14(5): 625-638.
2. King H, Aubert RE, Herman WH. Global burden of diabetes,1995-2025: prevalence, numerical estimates, and projections. Diabetes Care.1998; 21(9): 1414-1431.
3. Kavishankar GB, Lakshmidevi N, Murthy SM, Prakash HS and Niranjana SR. Diabetes and medicinal plants-A review. International Jr of Pharmacy and Biomedical Sciences. 2011; 2: 65-80.
4. Jarald E, Joshi SB, Jain DC. Diabetes and herbal medicines. Iranian Journal of Pharmacology and therapeutics.2008; 7: 97-108.
5. Sarker SD, Uddin SJ, Shilpi JA, Razina R, Mohsina FME, Lutfun N. Neuropharmacological Properties of Xylocarpus Moluccensis. Fitoterapia.2007; 78, 107-111.
6. Lakshmi V, Gupta P, An overview of the genus Xylocarpus. Nat Prod Res.2008; 22(14): 1197-1224.
7. Saxena E, Babu UV. Constituents of carapa grantatum. Fitoterapia, 2001;72: 186-87.
8. Srivastava AK, Srivastava S, Srivastava SP, Raina D, Ahmad R, Srivastava MN, Raghubir R, Lakshmi V. Antihyperglycaemic and antidyslipidaemic activity in ethanolic extract of a marine mangrove Xylocarpus granatum. Journal of Pharmaceutical and Biomedical Sciences, 2011; 9 (22): 1-12.
9. Kishi K, Muromoto N, Nakaya Y, Miyata I, Hagi A, Hayashi H, Ebina Y. Bradykinin directlytriggers GLUT4 translocation via an insulin-independent pathway. Diabetes. 1998; 47(4):550-8.
10. Ueyama A, Yaworsky KL, Wang Q, Ebina Y, Klip A. GLUT-4myc ectopic expression in L6 myoblasts generates a GLUT-4-specific pool conferring insulin sensitivity Am. J. Physiol. 1999;277:, E572-8.
11. Tamrakar AK, Schertzer JD, Chiu TT, Foley KP, Bilan PJ, Philpott DJ, Klip A. NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance. Endocrinology.2010; 151: 5624-5637.
12. Tamrakar AK, Singh AB, Srivastava AK. Db/+ mice as an alternate model in antidiabetic drug discovery research. Archives of Medical Research, 2009; 40: 73-78.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent J Biol Chem. 1951;193: 265-275.
14. Porter EV, Chassy BM. Glucokinase from Streptococcus mutans. Methods Enzymol. 1982; 90: 25-30.
15. Bucher T. and Pfleiderer G. Pyruvate kinase from muscle. In Colowick, S. P. and Kaplan, N. O. (eds), Methods in Enzymology. Academic Press, London, 1955;Vol. 1, pp. 435-440.
16. Berthet J, Jacques P, Hers HG, De Duve C. Influence de l'insuline et du glucagon sur la synthèse du glycogène hépatique. Biochim. Biophys. Acta, 1956;20(1):190-200.
17. Taussky HH, Shorr E. A microcolorimetric method for the determina-tion of inorganic phosphate. J Biol Chem 1953;202:675 e685.
18. Hubscher G, West GR. Specific assays of some phosphatase in subcellular fractions of small intestinal mucosa. Nature 1965;205:799 e800.
19. Ulm EH, Pogell BM, De Maine MM, Libby CB, Benkovic SJ: Fructose-1,6-diphosphatase from rabbit liver. Methods Enzymol 1975;42:369-374.
20. Ward CW, Castro GA, Fairbairn D. Carbon dioxide fixation and phosphoenolpyruvatecarboxykinase metabolism in Trichinella spiralis larvae. J Parasitol 1969; 55:67-71.
21. Pistia-Brueggeman G, Hollingsworth RI. A preparation and screening strategy for glucosidase inhibitors. Tetrahedron, 2001; 57: 8773-8778.
22. Latha RCR, Daisy P. Influence of Terminalia bellerica fruit extracts on Biochemical parameters in STZ Diabetic rats, International Journal of Pharmacology.2010; 6(2): 89-96.
23. Girald A, Madani SS, Boukortt F, Mustapha, Malki MC, Belleville J, Prost J. Fructose-enriched diet modifies antioxidant status and lipid metabolism in spontaneously hypertensive rats. J. Nutrition, 2006; 22: 758-766.
24. Huang W, Dedousis N, and O'Doherty RM. Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion. J Appl Physiol.2007;102: 2260-2265.
25. Hickman IJ and Greame MA. Impact of Diabetes on the Severity of Liver Disease The American Journal of Medicine, 2007; 120: 829-834.
26. Valentovic MA, Napoleon Alejandro d, Carpenter AB, Brown PI, Ramose K. Streptozotocin (STZ) diabetes enhances benzo(α)pyrene induced renal injury in Sprague Dawley rats. Toxicol Lett. 2006;164 (3): 214-220.
27. Srinivasan K, Viswanad B, Asrat L., Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening Pharmacol Res.2005; 52(4): 313-320.
28. Shukla P, Srivastava SP, Srivastava R, Rawat A, Srivastava A, Pratap R. Synthesis and antidyslipidemic activity of chalcone fibrates Bioorg med chem letters.2011; 21(11):3475-3478.
29. Duseja A, Das A, Dhiman RK, Chawla YK, Thumburu KK, Bhadada S, Bhansali A. Metformin is effective in achieving biochemical response in patients with non alcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Annals of Hepatology.2007;6(4): 222-226.
30. Verma AK, Singh H, Satyanarayana M, Srivastava SP, Tiwari P, Singh AB, Dwivedi AK, Singh SK, Srivastava M, Nath C, Raghubir R, Srivastava AK, Pratap R. Flavone-based novel antidiabetic and antidyslipidemic agents. J Med Chem. 2012; 55 (10): 4551-4567.
31. Huupponen RK, Viikari JS, Saarimaa H. Correlation of serum lipids with diabetes control in sulfonylurea-treated diabetic patients Diabetes Care.1984; 7: 575-578.
32. Kim JK, Fillmore J J, Chen Y Yuc, Moore IK, Pypaert M et al. Tissue specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. acad. Sci USA 2001; 98: 7522-7527.
33. Anderson J W, and Zakim D. The influence of alloxan-diabetes and fasting on glycolytic and gluconeogenic enzyme activities of rat intestinal mucosa and liver. Biochim Biophys Act 1970; 201: 236-241.
34. Herberg L, Coleman DL. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism. 1977;26(1):59-99.
35. Sochor M, Kunjara S, Baquer NZ, McLean P: Regulation of glucose metabolism in livers and kidneys of NOD mice. Diabetes 1991;40(11):1467-1471.
36. Sochor M, Baquer NZ, McLean P. Glucose over and underutilization in diabetes: Comparative studies on the changes in activities of enzymes of glucose metabolism in rat kidney and liver. Mol. Physiol. 1985;7:51-68.
37. Rathi SS, Grover JK, Vats V. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother Res. 2002;16(3):236-43.
38. Murphy ED and Anderson JW Tissue Glycolytic and Gluconeogenic Enzyme Activities in Mildly and Moderately Diabetic Rats: Influence of Tolbutamide Administration Endocrinology. 1974; 94(1): 27-34.
39. Weber G, Lea MA, Fisher EA. Regulatory pattern of liver carbohydrate metabolizing enzymes;insulin as an inducer of key glycolytic enzymes. Enzymology Biology Clinics (Basel) 1966;7: 11-24.
40. Berg, J. M., Tymoczko, J. L. and Stryrer, L. Biochem. W.H. Freeman and Company, New York, 2001;425-464.
41. Chandramohan, G., Ignacimuthu, S., Pugalendi. "A novel compound from Casearia esculenta (Roxb.) root and its effect on carbohydrate metabolism in streptozotocin-diabetic rats, "European J. Pharmacol, 2008; 590: 437-443.
42. Li YG, Ji DF, Zhong S, Lv ZQ, Lin TB, Chen S, Hu GY. Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabetic mice. Journal of Ethnopharmacology. 2011;134(3):961-70.
43. Stuart AR, Gulve EA, Minghan W: Chemistry and biochemistry of type 2diabetes. Chem Rev 2004; 104:1255-1282.
44. Casirola DM, Ferraris RP: alpha-Glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice. Metabolism. 2006; 55:832-841.